Skip to content

Write a review and win an AirPods Pro or MacBook Air - See the draw

Home health / DCT (decentralized trials)

Science 37

Public sources indicate Science 37 operates in home health / dct with a focus on virtual trial platform and a global footprint.

Home health / DCT (decentralized trials)

Vendor description

About

Public sources indicate Science 37 operates in home health / dct with a focus on virtual trial platform and a global footprint.

Positioning

Public sources indicate Science 37 operates in home health / dct with a focus on virtual trial platform and a global footprint.

Best for

Hybrid or decentralized studies needing patient-facing services

Strengths
  • Patient convenience
  • decentralized execution
  • visit flexibility
Limitations
  • Not every protocol element can be decentralized

Approved customer reviews

Write a review
No reviews yet

Be the first customer to share verified experience with this vendor.

Review snapshot

External review summary

Science 37s public employee reputation is clearly weak in this pass. Glassdoor metrics are low,and Reddit discussion repeatedly flags layoffs,instability,and concerns about long-term job security despite the remote/DCT model being attractive on paper. Employees appear much less confident in leadership and stability than in the companys market story.

Positive themes

Remote/DCT concept - some role appeal - Remote - DCT concept

Watch-outs

Layoffs - instability - low recommendation - weak confidence in leadership

Employee sentiment

Negative

Pricing

Price band

$

Key facts

HQ countryGlobal
GeographyGlobal
Service modelHome health / DCT (decentralized trials)
Customer segmentmixed
Study phasesPhase I, Phase II, Phase III, Phase IV
Trial scaleFocused global studies
Therapeutic areasGeneralist
Last reviewed2026-03-28

Related vendors

Editorial ranking

See how Science 37 compares - best Home health / DCT (decentralized trials) vendors for clinical trials.